12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million.
  • Cryo-Cell International (AMEX:CCEL) shares increased by 27.94% to $9.98. The market value of their outstanding shares is at $80.8 million.
  • Fresh2 Group (NASDAQ:FRES) shares moved upwards by 18.33% to $0.71. The market value of their outstanding shares is at $17.4 million.
  • Inspire Veterinary (NASDAQ:IVP) shares rose 16.79% to $0.04. The company's market cap stands at $3.9 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock increased by 15.82% to $4.99. The market value of their outstanding shares is at $11.1 million.
  • Genprex (NASDAQ:GNPX) stock increased by 11.47% to $2.36. The company's market cap stands at $4.5 million.

Losers

  • Processa Pharma (NASDAQ:PCSA) shares fell 15.6% to $2.05 during Friday's pre-market session. The market value of their outstanding shares is at $5.8 million.
  • SCWorx (NASDAQ:WORX) shares decreased by 15.58% to $2.33. The market value of their outstanding shares is at $2.8 million.
  • Nuwellis (NASDAQ:NUWE) shares declined by 13.85% to $0.25. The market value of their outstanding shares is at $1.6 million.
  • Aclarion (NASDAQ:ACON) stock fell 12.79% to $0.34. The company's market cap stands at $2.4 million.
  • Vincerx Pharma (NASDAQ:VINC) shares decreased by 12.13% to $0.79. The company's market cap stands at $16.8 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) shares decreased by 12.03% to $1.38. The company's market cap stands at $6.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
avatar
Share your ideas here…

All Comments

What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.